Journal of Biological Response Modifiers
-
Publication Venue For
- A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity.. 9:522-527. 1990
- Implications of leukoregulin to autologous tumor-specific human T-cell populations.. 9:387-394. 1990
- Dissociation of thymidine incorporation and transferrin receptor expression from cell growth and c-myc accumulation in alpha-interferon-treated cells.. 9:212-220. 1990
- Phase I studies of recombinant interferon-gamma.. 9:185-193. 1990
- Cytokine augmentation of human immunodeficiency virus type 1 (HIV-1) gp120-specific cellular cytotoxicity.. 8:501-510. 1989
- Schedule-dependent enhanced lethality with combined administration of actinomycin D and tumor necrosis factor in mice.. 8:287-296. 1989
- Phase I and II studies of the combination of recombinant human interferon-gamma and 5-fluorouracil in patients with advanced colorectal carcinoma.. 8:140-146. 1989
- Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies.. 8:37-52. 1989
- EXVIVO ACTIVATION OF CELLULAR CYTO-TOXIC RESPONSES IN HIV-1 INFECTED PATIENTS 1989